ACORDA THERAPEUTICS

acorda-therapeutics-logo

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. The first product for which the Company completed clinical development, Ampyra (dalfampridine) Extended Release Tablets (Ampyra), was approved by the United States Food and Drug Administration (FD... A) in January 2010, as a treatment to improve walking in patients with MS. Ampyra is an extended-release tablet formulation of dalfampridine (4-aminopyridine (4-AP)), which was previously referred to as fampridine. Acorda's marketed product, Zanaflex Capsules, is approved by the FDA as a short-acting drug for the management of spasticity.

#People #Financial #Website #More

ACORDA THERAPEUTICS

Social Links:

Industry:
Biotechnology Developer Platform Health Care

Founded:
1995-01-01

Address:
Hawthorne, New York, United States

Country:
United States

Website Url:
http://www.acorda.com

Total Employee:
251+

Status:
Active

Contact:
(914) 347-4300

Email Addresses:
[email protected]

Total Funding:
151.6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager Content Delivery Network Font Awesome Apache Mobile Non Scaleable Content IPv6 ReCAPTCHA



Current Advisors List

ian-smith_image

Ian Smith Member of Board @ Acorda Therapeutics
Board_member

not_available_image

Sandra Panem Board of Directors @ Acorda Therapeutics
Board_member

Current Employees Featured

lauren-sabella_image

Lauren Sabella
Lauren Sabella Chief Commercial Officer @ Acorda Therapeutics
Chief Commercial Officer
2015-02-01

ron-cohen_image

Ron Cohen
Ron Cohen Founder, President and CEO @ Acorda Therapeutics
Founder, President and CEO
1995-01-01

burkhard-blank_image

Burkhard Blank
Burkhard Blank Chief Medical Officer & Head of R&D @ Acorda Therapeutics
Chief Medical Officer & Head of R&D
2016-01-01

denise-duca_image

Denise Duca
Denise Duca Executive Vice President, Human Resources @ Acorda Therapeutics
Executive Vice President, Human Resources
2015-01-01

Founder


ron-cohen_image

Ron Cohen

Stock Details


Company's stock symbol is NASDAQ:ACOR

Acquisitions List

Date Company Article Price
2016-01-19 Biotie Therapies Biotie Therapies acquired by Acorda Therapeutics 363 M USD
2014-09-24 Civitas Therapeutics Civitas Therapeutics acquired by Acorda Therapeutics 525 M USD
2012-02-17 Neuronex Neuronex acquired by Acorda Therapeutics N/A

Investors List

paul-capital-healthcare_image

Paul Capital

Paul Capital investment in Post-IPO Equity - Acorda Therapeutics

national-institute-of-neurological-disorders-and-stroke_image

National Institute of Neurological Disorders and Stroke

National Institute of Neurological Disorders and Stroke investment in Grant - Acorda Therapeutics

new-york-state-department-of-health_image

New York State Department of Health

New York State Department of Health investment in Grant - Acorda Therapeutics

cross-atlantic-partners_image

Cross Atlantic Partners

Cross Atlantic Partners investment in Series B - Acorda Therapeutics

j-p-morgan-securities-inc_image

J.P. Morgan Securities Inc.

J.P. Morgan Securities Inc. investment in Series B - Acorda Therapeutics

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series B - Acorda Therapeutics

mpm-capital_image

MPM Capital

MPM Capital investment in Series B - Acorda Therapeutics

forward-ventures_image

Forward Ventures

Forward Ventures investment in Series B - Acorda Therapeutics

abn-amro_image

ABN AMRO Fund

ABN AMRO Fund investment in Series B - Acorda Therapeutics

easton-capital_image

Easton Capital

Easton Capital investment in Series B - Acorda Therapeutics

Official Site Inspections

http://www.acorda.com Semrush global rank: 4.72 M Semrush visits lastest month: 2.01 K

  • Host name: 44.233.12.198.host.secureserver.net
  • IP address: 198.12.233.44
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Acorda Therapeutics" on Search Engine